@A_May_MD @deathtouch2k Same HR, different trials. S1801: phase 2, n=313, clinically detectable III–IV, EFS. INTerpath-001: phase 3, n=1137, resected IIB–IV incl. node-negative IIB/C where neoadjuvant isn't on the table, RFS. Cross-trial HR matching is a coincidence, not a finding. #ESMO26